General Info
Armistice Capital is a global, value-oriented and event-driven hedge fund focused primarily on the health care and consumer sector.
Location: New York
Country:
Industries:
Investment Regions:
Investment Stages: late-stage
Website: http://www.armisticecapital.com/
vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: I found evidence of Armistice Capital making investments in 2024 and 2025. Specific investments: Armistice Capital invested in Assembly Biosciences (reported June 17, 2024) and acquired new stakes in 60 Degrees Pharmaceuticals and Cadrenal Therapeutics (reported Nov 14-15, 2024). Additionally, news articles indicate trading activity and fund performance in 2025. The most recent confirmed investment/trade activity is in 2025 (articles dated April-May 2025 and legal filings in Aug 2025), which is within the past 6 months to 3 months window from the reference date. Therefore the investor falls into the category corresponding to last known investment between 6 and 3 months ago.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Armistice Capital
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI